Table 3 Results of meta-analysis for secondary outcomes
Outcomes | No. of studies | OR (95 % CI) | P |
|---|---|---|---|
30-day bleeding | |||
High-risk PCI without CS | 2 | 1.585 (1.124, 2.235) | 0.009* |
MI with CS | 1 | 0.992 (0.668, 1.472) | 0.967 |
MI without CS | 2 | 2.451 (0.826, 7.273) | 0.106 |
Total | 5 | 1.391 (0.864, 2.238) | 0.174 |
30-day reinfarction rate | |||
High-risk PCI without CS | 2 | 0.851 (0.517, 1.400) | 0.525 |
MI with CS | 1 | 2.273 (0.692, 7.464) | 0.176 |
MI without CS | 1 | 0.530 (0.047, 6.028) | 0.609 |
Total | 4 | 0.964 (0.614, 1.514) | 0.875 |
30-day revascularization rate | |||
High-risk PCI without CS | 2 | 0.749 (0.180, 3.118) | 0.691 |
MI with CS | 1 | 0.883 (0.501, 1.554) | 0.665 |
MI without CS | 1 | 2.204 (0.194, 25.071) | 0.524 |
Total | 4 | 0.900 (0.538, 1.505) | 0.688 |
30-day stroke rate | |||
High-risk PCI without CS | 2 | 7.959 (0.974, 65.021) | 0.053 |
MI with CS | 1 | 0.393 (0.076, 2.043) | 0.267 |
MI without CS | 1 | 3.323 (0.342, 32.271) | 0.301 |
Total | 4 | 1.576 (0.511, 4.861) | |